Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ZETA vs GSK✓SelectedUSD · GSKZETA vs GSK performance historyLatest closeAs of-5.12%11/19
Stock and ETF performance explorer

ZETA vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+262.4%
GSK return
+50.1%
Excess return
+212.3%
Maximum drawdown
-70.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-5.1%-1.6%-3.6%-5.0%
7D-13.5%-4.7%-8.8%-13.2%
30D-4.0%-4.7%+0.7%-3.6%
3M+11.9%-8.8%+20.7%+12.8%
6M+76.1%-4.6%+80.7%+76.6%
YTD+58.3%+1.0%+57.3%+56.7%
1Y+90.9%+6.9%+84.0%+87.4%
3Y+280.4%+52.5%+227.9%+252.6%
5Y+281.8%+40.3%+241.5%+253.3%
All+262.4%+50.1%+212.3%+242.4%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling